X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (221) 221
Publication (13) 13
Book / eBook (8) 8
Patent (5) 5
Magazine Article (4) 4
Book Chapter (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
oncology (87) 87
female (78) 78
middle aged (78) 78
radiotherapy (76) 76
male (71) 71
aged (66) 66
adult (47) 47
combined modality therapy (42) 42
radiotherapy dosage (40) 40
radiology, nuclear medicine & medical imaging (39) 39
cancer (37) 37
neoplasm staging (32) 32
aged, 80 and over (30) 30
index medicus (29) 29
prognosis (28) 28
survival rate (28) 28
radiation (27) 27
irradiation (25) 25
radiation therapy (25) 25
follow-up studies (24) 24
surgery (24) 24
therapy (24) 24
chemotherapy (21) 21
carcinoma (20) 20
care and treatment (20) 20
survival (20) 20
prostatic neoplasms - radiotherapy (19) 19
radiotherapy - adverse effects (19) 19
carcinoma, squamous cell - radiotherapy (18) 18
disease-free survival (18) 18
prostate cancer (18) 18
retrospective studies (18) 18
uterine cervical neoplasms - radiotherapy (18) 18
patients (17) 17
radiology (17) 17
survival analysis (17) 17
brachytherapy (16) 16
neoplasms (16) 16
radiation-therapy (16) 16
radiology and nuclear medicine (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
clinical trials (15) 15
prostatic neoplasms - pathology (15) 15
treatment outcome (14) 14
adenocarcinoma - pathology (13) 13
prospective studies (13) 13
time factors (13) 13
adenocarcinoma - radiotherapy (12) 12
brain neoplasms - radiotherapy (12) 12
carcinoma, squamous cell - mortality (12) 12
carcinoma, squamous cell - pathology (12) 12
carcinomas (12) 12
lymphatic metastasis (12) 12
risk (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
body (11) 11
medicine (11) 11
prostatic neoplasms - mortality (11) 11
research (11) 11
analysis (10) 10
cisplatin - administration & dosage (10) 10
diseases (10) 10
fluorouracil - administration & dosage (10) 10
head and neck neoplasms - radiotherapy (10) 10
hematology, oncology and palliative medicine (10) 10
hyperfractionation (10) 10
multivariate analysis (10) 10
tumors (10) 10
article (9) 9
brain neoplasms - secondary (9) 9
cervical cancer (9) 9
lung neoplasms - radiotherapy (9) 9
nuclear medicine (9) 9
uterine cervical neoplasms - pathology (9) 9
uterine cervix (9) 9
adenocarcinoma (8) 8
brain neoplasms - mortality (8) 8
carcinoma, squamous cell - surgery (8) 8
health aspects (8) 8
metastases (8) 8
proportional hazards models (8) 8
randomized-trial (8) 8
550603 - medicine- external radiation in therapy- (7) 7
adenocarcinoma - surgery (7) 7
adolescent (7) 7
african americans (7) 7
animals (7) 7
antigen (7) 7
cisplatin (7) 7
head (7) 7
karnofsky performance status (7) 7
melanoma - radiotherapy (7) 7
men (7) 7
neoplasm recurrence, local (7) 7
organs (7) 7
prostate-specific antigen - blood (7) 7
prostatic neoplasms - drug therapy (7) 7
radical prostatectomy (7) 7
radiology & nuclear medicine (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Criminology - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1974, ISBN 9780801640704, x, 177
Book
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 2, pp. 107 - 118
A course of androgen-deprivation therapy before and during radiotherapy prolonged 10-year survival by about 7% among men with intermediate-risk prostate... 
MEDICINE, GENERAL & INTERNAL | EXTERNAL-BEAM RADIOTHERAPY | THERAPY ONCOLOGY GROUP | DOSE-ESCALATION TRIAL | FOLLOW-UP | RADICAL PROSTATECTOMY | RANDOMIZED CONTROLLED-TRIAL | SUPPRESSION | HORMONAL-THERAPY | GROUP RTOG | RADIATION-THERAPY | Multivariate Analysis | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Risk | Radiotherapy - adverse effects | Flutamide - adverse effects | Prostate - pathology | Leuprolide - administration & dosage | Aged, 80 and over | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Gonadotropin-Releasing Hormone - agonists | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Survival Rate | Combined Modality Therapy | Erectile Dysfunction - etiology | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Leuprolide - adverse effects | Aged | Flutamide - administration & dosage | Androgen Antagonists - adverse effects | Usage | Care and treatment | Hormone therapy | Diagnosis | Radiotherapy | Health aspects | Prostate cancer | Adenocarcinoma | Short term | Lymphatic system | Risk groups | Prostate-specific antigen | Mortality | Blood tests | Oncology | Metastasis | Radiation therapy | Phosphatase | Cancer therapies | Survival | Metastases | Androgens | Biopsy | Surgery | Prostate | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 86, Issue 1, pp. 27 - 33
Purpose A multi-institutional phase 2 trial assessed the utility of dose-painted intensity modulated radiation therapy (DP-IMRT) in reducing grade 2+ combined... 
Radiology | Hematology, Oncology and Palliative Medicine | CANCER-PATIENTS | ONCOLOGY | CONCURRENT CHEMOTHERAPY | RANDOMIZED-TRIAL | TOXICITY | RADIOTHERAPY | FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Urogenital System - radiation effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Gastrointestinal Tract - radiation effects | Male | Anal Canal | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Transitional Cell - therapy | Radiotherapy, Intensity-Modulated - adverse effects | Radiotherapy Planning, Computer-Assisted - standards | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Aged, 80 and over | Anus Neoplasms - therapy | Adult | Dose Fractionation | Female | Mitomycin - adverse effects | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Drug Administration Schedule | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Anus Neoplasms - pathology | Radiography | Analysis of Variance | Carcinoma, Transitional Cell - pathology | Radiation Injuries - prevention & control | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Mitomycin - administration & dosage | Sects | Mitomycin | Nuclear radiation | Analysis | Clinical trials | Radiotherapy | Cancer | Fluorouracil | Index Medicus | AUGER ELECTRON SPECTROSCOPY | REVIEWS | PATIENTS | DISEASE INCIDENCE | URACILS | RADIATION QUALITY | METASTASES | MITOMYCIN | RADIATION DOSES | PLANNING | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 84, Issue 5, pp. 1198 - 1205
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2016, Volume 83, Issue 5, pp. AB268 - AB268
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 69, Issue 3, pp. 646 - 655
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2004, Volume 22, Issue 5, pp. 872 - 880
Purpose To report mature results of a randomized trial that compared extended-field radiotherapy (EFRT) versus pelvic radiotherapy with concomitant... 
BULKY STAGE-IB | IIB | ONCOLOGY | CISPLATIN CHEMOTHERAPY | LYMPH-NODES | RANDOMIZED-TRIAL | RADIOTHERAPY | CARCINOMA | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Neoplasm Invasiveness - prevention & control | Carcinoma, Adenosquamous - drug therapy | Reference Values | Uterine Cervical Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Pelvis - radiation effects | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Neoplasm Invasiveness - pathology | Carcinoma, Adenosquamous - mortality | Adult | Female | Aorta, Abdominal - radiation effects | Uterine Cervical Neoplasms - mortality | Adenocarcinoma - radiotherapy | Carcinoma, Adenosquamous - pathology | Uterine Cervical Neoplasms - radiotherapy | Risk Assessment | Brachytherapy - methods | Probability | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Combined Modality Therapy | Radiation Dosage | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Survival Analysis | Aged | Neoplasm Staging | Dose-Response Relationship, Radiation | Adenocarcinoma - mortality
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 19, pp. 1937 - 1944
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1504 - 1515
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 2, pp. 294 - 302
Purpose Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | DEPRIVATION | ORAL ETOPOSIDE | GROUP PROTOCOL 92-02 | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | III TRIAL | DURATION | ESTRAMUSTINE | PACLITAXEL | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Hormonal - adverse effects | Early Termination of Clinical Trials | Neoplasm Grading | Time Factors | Chemotherapy, Adjuvant - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Androgen Antagonists - therapeutic use | Aged | Combined Modality Therapy - methods | Estramustine - therapeutic use | Clinical trials | Radiotherapy | Health aspects | Adjuvant treatment | Radiation | Cancer | Index Medicus | PROSTATE | LUTEINIZING HORMONE | PATIENTS | NEOPLASMS | CLINICAL TRIALS | FAILURES | METASTASES | ANTIGENS | TOXICITY | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | LIBERINS | INHIBITION | DATA | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | ANDROGENS
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2014, Volume 32, Issue 23, pp. 2486 - 2495
Journal Article